Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael E. Wechsler, MD

Articles by Michael E. Wechsler, MD

ATS 2026 Highlighted Collaboration and Innovation in Pulmonary Medicine

BySabrina McCrear,Njira L. Lugogo, MD, MS,Mark Metersky, MD,Jerry A. Krishnan, MD, PhD,Yet Khor, MD, PhD,Michael E. Wechsler, MD

May 27th 2026

ATS 2026 showcased new pulmonary therapies, clinical trials, and cross-specialty collaboration to improve patient care.

Michael Wechsler, MD, MMSc, discussed how tezepelumab may address multiple severe asthma outcomes simultaneously.

Tezepelumab Showed Broad Benefit Across Asthma Outcomes: Michael Wechsler, MD, MMSc

BySabrina McCrear,Michael E. Wechsler, MD

May 19th 2026

SUNRISE data showed tezepelumab improved asthma outcomes while reducing steroid dependence in severe asthma.

Dr Michael Wechsler

SUNRISE Data Support Steroid Reduction in Severe Asthma: Michael Wechsler, MD, MMSc

BySabrina McCrear,Michael E. Wechsler, MD

May 19th 2026

SUNRISE trial data showed tezepelumab reduced oral steroid use while maintaining asthma control in severe asthma.

Discussing the COSTS of Asthma: Controlling Outcomes, Symptoms, and Treatment Strategies

ByDonald A. Bukstein, MD,Craig A. Jones, MD,Dennis K. Ledford, MD,Peter Smith, MD,Michael E. Wechsler, MD,Frank L. Urbano, MD, FACP

October 17th 2005

Latest Updated Articles

Discussing the COSTS of Asthma: Controlling Outcomes, Symptoms, and Treatment Strategies
October 17th 2005

Trending on AJMC

Special Report: The Oncology Care Model, 10 Years Later

FDA Approves Tocilizumab-bavi for CAR-T-Induced CRS, Pediatric COVID-19

AI Model Challenges Genomic Classifiers in Early Breast Cancer Risk Stratification: Nancy Lin, MD

Weight Loss Drugs Can Improve Outcomes in Patients With Heart Failure and Obesity: Sandra Chaparro, MD

Shields Health Solutions Partners With Baptist Health on Specialty Pharmacy